Top Markets
#1 TENDIES TENDIES +86.60%
#2 Akedo Akedo +85.57%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +41.25%
#5 Bitway Bitway +30.90%
#6 Mubarak Mubarak +30.39%
#7 MultiversX MultiversX +27.18%
#8 Cash Cat Cash Cat +23.24%
#9 Palladium Network Palladium Network +22.68%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
TENDIES TENDIES
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Pozycja w akcjach #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Cena akcji
$0.51647906
Kapitalizacja rynkowa
$226.16M
Zmiana (1 dzień)
5.29%
Zmiana (1 rok)
66.66%
Kraj
IN
Handel Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategoria

Healthcare
Zyski dla Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Shukra Pharmaceuticals Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Shukra Pharmaceuticals Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$1.21B -
HK